TD Cowen Maintains Buy on Ovintiv, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 65.4%

Neg 0% Neu 0% Pos 65.4%

TD Cowen analyst Robert Hodges maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $58 to $60.

Comments

No comments yet. Be the first!